NCT04767958

The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing

The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing to Optimize Patient Care, Resource Allocation and Safety for Frontline Staff

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 89 (actual)
• Sponsor: Ottawa Heart Institute Research Corporation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being conducted to study the use and application of a point-of-care (POC) Covid-19 test developed by Spartan BioSciences and recently approved for clinical use by Health Canada.

Detailed description

This RAPID COVID-19 study is a prospective, unblinded clinical trial. POC testing utilizing the Spartan Cube COVID-19 platform will be performed on a cohort of 2200 hospitalized patients who have been tested for COVID-19. This cohort will be divided into three groups: 1. patients consulted upon by ICU, internal medicine, or cardiology for admission to the hospital 2. patients undergoing cardiac testing and/or procedures 3. patients awaiting surgery The results from the POC test will be compared to the results from the traditional hospital core lab test to determine sensitivity and specificity of the POC test. An additional cohort of 500 quarantined health care workers will have the POC test performed and compared with the results from the traditional hospital core lab test.

Conditions

• Covid19

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Spartan COVID-19 Platform	Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform

Timeline

• Start date: 2021-03-19
• Primary completion: 2021-05-31
• Completion: 2021-08-31
• First posted: 2021-02-23
• Last updated: 2022-05-02

Locations

1 site across 1 country: Canada